Analyst Activity – Janney Montgomery Scott Initiates Coverage On NASDAQ:SMMT – Summit Therapeutics (NASDAQ:SMMT) With a Buy

ME Staff
-
0

Analyst Ratings For NASDAQ:SMMT – Summit Therapeutics (NASDAQ:SMMT)

Today, Janney Montgomery Scott initiated coverage on NASDAQ:SMMT – Summit Therapeutics (NASDAQ:SMMT) with a Buy with a price target of $27.00.

Some recent analyst ratings include

  • 5/2/2018-Janney Montgomery Scott initiated coverage with a Buy rating.
  • 2/13/2018-BTIG Research initiated coverage with a Buy rating.
  • 1/4/2018-SunTrust Banks initiated coverage with a Buy rating.
  • 10/16/2017-Canaccord Genuity Reiterated Rating of Buy.


    Recent Trading Activity for NASDAQ:SMMT – Summit Therapeutics (NASDAQ:SMMT)
    Shares of NASDAQ:SMMT – Summit Therapeutics closed the previous trading session at 13.49 up +0.31 2.35% with 13.5 shares trading hands.